BDBM591748 Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent-2-ynoyl)azetidin-3-yl)oxy)-N-((63S,4S,Z)-11-ethyl-12-(2-((S)-1-methoxyethyl)pyridin-3-yl)-10,10-dimethyl-5,7-dioxo-61,62,63,64,65,66-hexahydro-11H-8-oxa-2(4,2)-thiazola-1(5,3)-indola-6(1,3)-pyridazinacycloundecaphane-4-yl)propanamide::US11566007, Example A427

SMILES CCn1c(c2CC(C)(C)COC(=O)[C@@H]3CCCN(N3)C(=O)[C@H](Cc3nc(cs3)-c3ccc1c2c3)NC(=O)CCOC1CN(C1)C(=O)C#CC(C)(C)N(C)C)-c1cccnc1C(C)OC

InChI Key InChIKey=VSKGXRZZGOSVQU-PRUCUPDZSA-N

Data  12 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 591748   

TargetGTPase KRas [G12C](Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50: <10nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase NRas(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50:  5.50E+3nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G13C](Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50:  5.50E+3nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G13D](Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50:  5.50E+3nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [Q61H](Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50:  5.50E+3nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase NRas [Q61K](Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50:  5.50E+3nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase NRas [G12C](Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50: <10nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12S](Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50:  5.50E+3nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas(Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50:  5.50E+3nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase NRas [Q61R](Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50: >1.00E+4nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50: >1.00E+4nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12V](Homo sapiens (Human))
Revolution Medicines

US Patent
LigandPNGBDBM591748(Synthesis of 3-((1-(4-(dimethylamino)-4-methylpent...)
Affinity DataIC50:  5.50E+3nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent